Diagnostics

LEVY Health Secures $4.5 Million in Funding to Expedite Diagnosis and Care in Reproductive Health

The medical software company closes the care gap in reproductive health by providing clinical decision support and virtual care pathways. …

1 month ago

Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test

CAMBRIDGE, United Kingdom, Oct. 9, 2024 /PRNewswire/ -- Proteotype Diagnostics Ltd, in collaboration with the University of Southampton, has been awarded…

1 month ago

XORTX Initiates Precision Medicine Program

Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine MetabolismCALGARY, Alberta, Oct.…

2 months ago

Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care

Alliance marks first penKid licensing agreement for high throughput immunoassay.Partnership leverages SphingoTec's proficiency in acute kidney injury testing,and Beckman Coulter's…

2 months ago

Velsera and Diagnostics Longwood Partner to Revolutionize Access to Precision Genomics for Patients in Spain and Portugal

Announcing a Strategic Partnership to Enhance NGS Solutions in the Iberian Market LONDON, Oct. 8, 2024 /PRNewswire/ -- Velsera, a leading…

2 months ago

Axtria Showcases AI-Powered Innovations at PMSA 2024 Fall Symposium

Axtria showcases its collaboration with leading pharma companies on AI-driven insights, field force optimization, and data strategies. CHICAGO, Oct. 8,…

2 months ago

NanoViricides to Present at the Global AMR Summit 2024 Tomorrow

Dr. Diwan to Discuss "Shape-Shifting", "Trojan Horse", Pathogen-Directed Attack Capability of NanoViricides Platform Technology to Combat AMR SHELTON, CT /…

2 months ago

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to…

2 months ago

Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version

GANZIMMUN Diagnostics to Feature ColoAlert at the 57th Medizinische Woche Baden-BadenBERKELEY, Calif. and MAINZ, Germany, Oct. 08, 2024 (GLOBE NEWSWIRE)…

2 months ago